Assertio Therapeutics, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 13913 (Assertio Therapeutics, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
3
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
2
Dosage forms
2
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 2 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Cambia diclofenac potassium 50 mg/1 POWDER, FOR SOLUTION | 13913-0012-02 | — | On market | View → |
| ZIPSOR diclofenac potassium 25 mg/1 CAPSULE, LIQUID FILLED | 13913-0008-11 | — | Discontinued | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.